Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 21:2018:7924021.
doi: 10.1155/2018/7924021. eCollection 2018.

The Role of Oxidative Stress and Membrane Transport Systems during Endometriosis: A Fresh Look at a Busy Corner

Affiliations
Review

The Role of Oxidative Stress and Membrane Transport Systems during Endometriosis: A Fresh Look at a Busy Corner

Salvatore Giovanni Vitale et al. Oxid Med Cell Longev. .

Abstract

Endometriosis is a condition characterized by the presence of endometrial tissue outside the uterine cavity, leading to a chronic inflammatory reaction. It is one of the most widespread gynecological diseases with a 10-15% prevalence in the general female population, rising up to 30-45% in patients with infertility. Although it was first described in 1860, its etiology and pathogenesis are still unclear. It is now accepted that inflammation plays a central role in the development and progression of endometriosis. In particular, it is marked by an inflammatory process associated with the overproduction of an array of inflammatory mediators such as prostaglandins, metalloproteinases, cytokines, and chemokines. In addition, the growth and adhesion of endometrial cells in the peritoneal cavity due to reactive oxygen species (ROS) and free radicals lead to disease onset, its ensuing symptoms-among which pain and infertility. The aim of our review is to evaluate the role of oxidative stress and ROS in the pathogenesis of endometriosis and the efficacy of antioxidant therapy in the treatment and mitigation of its symptoms.

PubMed Disclaimer

References

    1. Giudice L. C., Kao L. C. Endometriosis. Lancet. 2004;364(9447):1789–1799. doi: 10.1016/S0140-6736(04)17403-5. - DOI - PubMed
    1. Laganà A. S., La Rosa V. L., Rapisarda A. M. C., et al. Anxiety and depression in patients with endometriosis: impact and management challenges. International Journal of Women’s Health. 2017;9:323–330. doi: 10.2147/IJWH.S119729. - DOI - PMC - PubMed
    1. Laganà A. S., Condemi I., Retto G., et al. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;194:30–33. doi: 10.1016/j.ejogrb.2015.08.015. - DOI - PubMed
    1. Laganà A. S., La Rosa V., Petrosino B., Vitale S. G. Comment on “Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study”. Journal of Affective Disorders. 2017;208:672–673. doi: 10.1016/j.jad.2016.07.016. - DOI - PubMed
    1. Vitale S. G., La Rosa V. L., Rapisarda A. M. C., Laganà A. S. Comment on: “Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference”. Journal of Psychosomatic Obstetrics & Gynaecology. 2017;38(1):81–82. doi: 10.1080/0167482X.2016.1244183. - DOI - PubMed

LinkOut - more resources